Dynamic complex exhibits broad-spectrum anti-tumour effects in glioma and A549 cells, indicating enhanced drug delivery potential.
The BTZ-AND complex exhibits broad-spectrum anti-tumour effects on U251 glioma cells and A549 cells. The BTZ-AND@BSA nanoparticles were prepared and demonstrated notable potential in cellular uptake and pH-responsive drug release behavior.
No takes yet. Share an insight, caveat, or question.
Qiao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: